• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用数据挖掘方法基于溶解度和渗透性识别药物亚类。

Application of data mining approach to identify drug subclasses based on solubility and permeability.

作者信息

Gatarić Biljana, Parojčić Jelena

机构信息

Department of Pharmaceutical Technology and Cosmetology, University of Banja Luka - Faculty of Medicine, Save Mrkalja 14, 78000, Banja Luka, Bosnia and Hercegovina.

Department of Pharmaceutical Technology and Cosmetology, University of Belgrade - Faculty of Pharmacy, Vojvode Stepe 450, 11221, Belgrade, Serbia.

出版信息

Biopharm Drug Dispos. 2019 Feb;40(2):51-61. doi: 10.1002/bdd.2170. Epub 2019 Feb 11.

DOI:10.1002/bdd.2170
PMID:30635908
Abstract

Solubility and permeability are recognized as key parameters governing drug intestinal absorption and represent the basis for biopharmaceutics drug classification. The Biopharmaceutics Classification System (BCS) is widely accepted and adopted by regulatory agencies. However, currently established low/high permeability and solubility boundaries are the subject of the ongoing scientific discussion. The aim of the present study was to apply data mining analysis on the selected drugs data set in order to develop a human permeability predictive model based on selected molecular descriptors, and to perform data clustering and classification to identify drug subclasses with respect to dose/solubility ratio (D/S) and effective permeability (P ). The P values predicted for 30 model drugs for which experimental human permeability data are not available were in good agreement with the reported fraction of drug absorbed. The results of clustering and classification analysis indicate the predominant influence of P over D/S. Two P cut-off values (1 × 10 and 2.7 × 10  cm/s) have been identified indicating the existence of an intermediate group of drugs with moderate permeability. Advanced computational analysis employed in the present study enabled the recognition of complex relationships and patterns within physicochemical and biopharmaceutical properties associated with drug bioperformance.

摘要

溶解度和渗透性被认为是决定药物肠道吸收的关键参数,也是生物药剂学药物分类的基础。生物药剂学分类系统(BCS)已被监管机构广泛接受和采用。然而,目前确定的低/高渗透性和溶解度界限仍是正在进行的科学讨论的主题。本研究的目的是对选定的药物数据集进行数据挖掘分析,以便基于选定的分子描述符开发一种人体渗透性预测模型,并进行数据聚类和分类,以识别关于剂量/溶解度比(D/S)和有效渗透率(P)的药物亚类。对30种无实验人体渗透性数据的模型药物预测的P值与报道的药物吸收分数高度一致。聚类和分类分析结果表明P对D/S的影响占主导地位。已确定两个P临界值(1×10和2.7×10 cm/s),表明存在一组具有中等渗透性的中间药物。本研究采用的先进计算分析能够识别与药物生物性能相关的物理化学和生物药剂学性质中的复杂关系和模式。

相似文献

1
Application of data mining approach to identify drug subclasses based on solubility and permeability.应用数据挖掘方法基于溶解度和渗透性识别药物亚类。
Biopharm Drug Dispos. 2019 Feb;40(2):51-61. doi: 10.1002/bdd.2170. Epub 2019 Feb 11.
2
Regional intestinal drug permeation: biopharmaceutics and drug development.区域肠道药物渗透:生物药剂学与药物开发
Eur J Pharm Sci. 2014 Jun 16;57:333-41. doi: 10.1016/j.ejps.2013.08.025. Epub 2013 Aug 27.
3
The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC.生物药剂学分类系统:体内预测溶出度(IPD)方法和体外-体内相关性的子类。
Eur J Pharm Sci. 2014 Jun 16;57:152-63. doi: 10.1016/j.ejps.2014.01.009. Epub 2014 Jan 28.
4
Is the full potential of the biopharmaceutics classification system reached?生物药剂学分类系统的全部潜力是否已得到充分发挥?
Eur J Pharm Sci. 2014 Jun 16;57:224-31. doi: 10.1016/j.ejps.2013.09.010. Epub 2013 Sep 25.
5
In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.在药物产品开发中的胃肠道药物吸收的计算预测:机制吸收模型 GI-Sim 的应用。
Eur J Pharm Sci. 2013 Jul 16;49(4):679-98. doi: 10.1016/j.ejps.2013.05.019. Epub 2013 May 29.
6
Biopharmaceutics classification and intestinal absorption of chikusetsusaponin IVa.柴胡皂苷 IVa 的生物药剂学分类和肠道吸收。
Biopharm Drug Dispos. 2019 Sep;40(8):276-281. doi: 10.1002/bdd.2200. Epub 2019 Jul 28.
7
The utility of rat jejunal permeability for biopharmaceutics classification system.大鼠空肠通透性在生物药剂学分类系统中的应用。
Drug Dev Ind Pharm. 2009 Dec;35(12):1496-502. doi: 10.3109/03639040903037199.
8
A non-binary biopharmaceutical classification of drugs: the ABΓ system.一种非二进制的药物生物制药分类法:ABΓ 系统。
Int J Pharm. 2014 Apr 10;464(1-2):85-90. doi: 10.1016/j.ijpharm.2014.01.022. Epub 2014 Jan 21.
9
Structure-based prediction of human intestinal membrane permeability for rapid in silico BCS classification.基于结构的人类肠道黏膜渗透性预测快速计算生物药剂学分类系统分类。
Biopharm Drug Dispos. 2013 Sep;34(6):321-35. doi: 10.1002/bdd.1848. Epub 2013 Jul 9.
10
A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan.美国、英国、西班牙和日本排名前200的口服药品的临时生物制药分类。
Mol Pharm. 2006 Nov-Dec;3(6):631-43. doi: 10.1021/mp0600182.

引用本文的文献

1
In Vitro Dissolution and in Silico Modeling Shortcuts in Bioequivalence Testing.生物等效性测试中的体外溶出和计算机模拟捷径
Pharmaceutics. 2020 Jan 4;12(1):45. doi: 10.3390/pharmaceutics12010045.
2
An Investigation into the Factors Governing Drug Absorption and Food Effect Prediction Based on Data Mining Methodology.基于数据挖掘方法的药物吸收影响因素调查及食物效应预测
AAPS J. 2019 Dec 10;22(1):11. doi: 10.1208/s12248-019-0394-y.